Immunological Study of Anti-M2 in Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis.

  • KITAMI Noriyuki
    the Department of Gastroenterology, Juntendo University School of Medicine
  • KOMADA Toshiyuki
    the Department of Gastroenterology, Juntendo University School of Medicine
  • ISHII Hideo
    the Department of Gastroenterology, Juntendo University School of Medicine
  • SHIMIZU Hidetake
    the Department of Gastroenterology, Juntendo University School of Medicine
  • ADACHI Hiroyasu
    the Department of Gastroenterology, Juntendo University School of Medicine
  • YAMAGUCHI Yasushi
    the Department of Gastroenterology, Juntendo University School of Medicine
  • KITAMURA Tsuneo
    the Department of Gastroenterology, Juntendo University School of Medicine
  • OIDE Hirosumi
    the Department of Gastroenterology, Juntendo University School of Medicine
  • MIYAZAKI Akihisa
    the Department of Gastroenterology, Juntendo University School of Medicine
  • ISHIKAWA Masakuni
    the Department of Gastroenterology, Juntendo University School of Medicine
  • ENDO Keiichiro
    the Department of Gastroenterology, Juntendo University School of Medicine
  • WATANABE Sumio
    the Department of Gastroenterology, Juntendo University School of Medicine
  • YOKOI Yukio
    the Department of Gastroenterology, Juntendo University School of Medicine
  • SATO Nobuhiro
    the Department of Gastroenterology, Juntendo University School of Medicine

この論文をさがす

抄録

We investigated the specificity of various autoantibodies in antimitochondrial antibody (AMA)-negative patients with primary biliary cirrhosis (PBC). We examined sera from 144 patients with PBC, 17 of whom were AMA negative by indirect immunofluorescence. The AMA-negative group showed a significantly higher positivity for smooth muscle antibody, but not for antinuclear antibody, as compared with the AMA-positive group. IgG class anti-PDH by enzyme-linked immunosorbent assay (ELIS A) were detected in 13 % of the AM A-negative group. However, all PBC patients showed positive IgG, IgA, and/or IgM class anti-M2 to the four M2 proteins by immunoblotting. These results suggest that the detection of IgG and IgM class anti-PDH and that of antibodies to the four M2 proteins increases the positivity of this ELISA method, and that detection of IgG, IgA, and IgM class anti-M2 to the four M2 proteins by immunoblotting is useful in diagnosing AMA-negative patients with PBC.<br>(Internal Medicine 34: 496-501, 1995)

収録刊行物

  • Internal Medicine

    Internal Medicine 34 (6), 496-501, 1995

    一般社団法人 日本内科学会

被引用文献 (24)*注記

もっと見る

参考文献 (40)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ